- Home
- ZVRA vs SWBI Comparison
ZVRA vs SWBI Comparison
Compare ZVRA & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- SWBI
- Stock Information
- Founded
- ZVRA 2006
- SWBI 1852
- Country
- ZVRA United States
- SWBI United States
- Employees
- ZVRA N/A
- SWBI N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- SWBI Ordnance And Accessories
- Sector
- ZVRA Health Care
- SWBI Industrials
- Exchange
- ZVRA Nasdaq
- SWBI Nasdaq
- Market Cap
- ZVRA 481.7M
- SWBI 429.0M
- IPO Year
- ZVRA 2015
- SWBI N/A
- Fundamental
- Price
- ZVRA $12.34
- SWBI $8.54
- Analyst Decision
- ZVRA Strong Buy
- SWBI Buy
- Analyst Count
- ZVRA 9
- SWBI 2
- Target Price
- ZVRA $23.25
- SWBI $12.00
- AVG Volume (30 Days)
- ZVRA 1.0M
- SWBI 1.3M
- Earning Date
- ZVRA 08-12-2025
- SWBI 09-04-2025
- Dividend Yield
- ZVRA N/A
- SWBI 6.09%
- EPS Growth
- ZVRA N/A
- SWBI N/A
- EPS
- ZVRA N/A
- SWBI 0.30
- Revenue
- ZVRA $40,588,000.00
- SWBI $474,661,000.00
- Revenue This Year
- ZVRA $292.31
- SWBI $8.53
- Revenue Next Year
- ZVRA $78.65
- SWBI N/A
- P/E Ratio
- ZVRA N/A
- SWBI $28.47
- Revenue Growth
- ZVRA 46.47
- SWBI N/A
- 52 Week Low
- ZVRA $5.45
- SWBI $8.38
- 52 Week High
- ZVRA $12.55
- SWBI $16.85
- Technical
- Relative Strength Index (RSI)
- ZVRA 84.06
- SWBI 36.14
- Support Level
- ZVRA $8.58
- SWBI $8.53
- Resistance Level
- ZVRA $12.37
- SWBI $8.85
- Average True Range (ATR)
- ZVRA 0.51
- SWBI 0.23
- MACD
- ZVRA 0.31
- SWBI -0.04
- Stochastic Oscillator
- ZVRA 98.47
- SWBI 20.54
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.